Diagnostic Utility of Array Comparative Genomic Hybridization in Children with Neurological Diseases

dc.authoridCokyaman, Turgay/0000-0002-7108-6839
dc.contributor.authorCokyaman, Turgay
dc.contributor.authorSılan, Fatma
dc.date.accessioned2025-01-27T20:39:10Z
dc.date.available2025-01-27T20:39:10Z
dc.date.issued2022
dc.departmentÇanakkale Onsekiz Mart Üniversitesi
dc.description.abstractIntroduction: We evaluated the contribution of array comparative genomic hybridization (aCGH) to the final diagnosis in children with neurocognitive disturbances or dysmorphic findings, but lacked a specific diagnosis. Materials and methods: Medical files of pediatric patients with neurocognitive disturbances who underwent aCGH analysis were reviewed retrospectively. Results: Of 155 patients, 77 copy number variations were detected and 50% (39/77) were considered causative. The aCGH's final diagnostic rate was 25.1% (39/155). Conclusion: With aCGH analysis, the diagnosis rate for patients with undiagnosed neurocognitive disturbances or dysmorphic syndrome may increase by 25-30%. If the phenotypic findings of the widely known neurocognitive disturbances cannot be identified during the initial clinical assessment, aCGH analysis may be beneficial.
dc.identifier.doi10.1080/15513815.2020.1764683
dc.identifier.endpage76
dc.identifier.issn1551-3815
dc.identifier.issn1551-3823
dc.identifier.issue1
dc.identifier.pmid32401632
dc.identifier.scopus2-s2.0-85085505221
dc.identifier.scopusqualityQ2
dc.identifier.startpage68
dc.identifier.urihttps://doi.org/10.1080/15513815.2020.1764683
dc.identifier.urihttps://hdl.handle.net/20.500.12428/23880
dc.identifier.volume41
dc.identifier.wosWOS:000534176200001
dc.identifier.wosqualityQ4
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakPubMed
dc.language.isoen
dc.publisherTaylor & Francis Inc
dc.relation.ispartofFetal and Pediatric Pathology
dc.relation.publicationcategoryinfo:eu-repo/semantics/openAccess
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.snmzKA_WoS_20250125
dc.subjectarray comparative genomic hybridization
dc.subjectintellectual disability
dc.subjectneurodevelopmental delay
dc.titleDiagnostic Utility of Array Comparative Genomic Hybridization in Children with Neurological Diseases
dc.typeArticle

Dosyalar